Skip Navigation


European Heart Journal Advance Access originally published online on June 23, 2005
European Heart Journal 2005 26(16):1576-1578; doi:10.1093/eurheartj/ehi375
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/16/1576    most recent
ehi375v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hobson, A.
Right arrow Articles by Kalra, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobson, A.
Right arrow Articles by Kalra, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Cardiology and nephrology: time for a more integrated approach to patient care?

Alex Hobson1, Philip A. Kalra2 and Paul R. Kalra3,*

1Wessex Cardiac Unit, Southampton, UK
2Department of Nephrology, Hope Hospital, Salford, UK
3Department of Cardiology, Portsmouth Hospitals NHS Trust, Portsmouth, UK

* Corresponding author: Department of Cardiology, Portsmouth Hospitals NHS Trust, St Mary's Hospital, Milton Road, Portsmouth PO3 6AD, UK. Tel: +44 2392 286000; fax: +44 2392 866067. E-mail address: paulkalra@aol.com

This editorial refers to ‘Atherosclerotic renovascular disease in chronic heart failure: should we intervene?’{dagger} by R. de Silva et al., on page 1596

The first 10% of the full text of this article appears below.

As the complexity of medicine develops at an exponential rate with an ever-increasing array of investigative and therapeutic strategies, greater subspecialization is inevitable. However, medical problems rarely confine themselves to a single organ and this is particularly apparent in patients with chronic disease of the heart and kidneys. Although cardiology has led the way in terms of establishing an evidence base on which therapeutic strategies can be recommended, conditions such as chronic heart failure (CHF) have increasing prevalence and despite various advances in treatment remain associated with poor outcomes. In addition, patients with significant co-morbidity (particularly nephrological) are generally excluded from clinical trials. There are many lessons to be learnt from specialists within other fields of medicine and this is no more apparent than between the nephrologist and the cardiologist whose patients can manifest many pathophysiological abnormalities that affect both organ systems.

Although there is clearly . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
Ramesh de Silva, Nikolay P. Nikitin, Sunil Bhandari, Anthony Nicholson, Andrew L. Clark, and John G.F. Cleland
EHJ 2005 26: 1596-1605. [Abstract] [Full Text]